The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19
There is a need for treatments to reduce coronavirus disease 2019 (COVID-19) mortality. Alpha-2 adrenergic receptor (α2 AR) agonists can dampen immune cell and inflammatory responses as well as improve oxygenation through physiologic respiratory parameters. Therefore, α2 AR agonists may be effective...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-01-01
|
| Sarja: | Frontiers in Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fmed.2021.797647/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|